Stopping for efficacy in single-arm phase II clinical trials

DOI10.1080/02664763.2021.1904846OpenAlexW3136063968MaRDI QIDQ5093024

M. Iftakhar Alam, Rezoanoor Rahman

Publication date: 26 July 2022

Published in: Journal of Applied Statistics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/02664763.2021.1904846

zbMATH Keywords

sample sizetwo-stage designoptimal designphase II trialsingle-arm trial

Mathematics Subject Classification ID

Applications of statistics (62Pxx)

Cites Work

• Bayesian two-stage design for phase II clinical trials with switching hypothesis tests
• Bayesian predictive monitoring with bivariate binary outcomes in phase II clinical trials
• Adaptive Two-Stage Designs for Single-Arm Phase IIA Cancer Clinical Trials
• One-Sample Multiple Testing Procedure for Phase II Clinical Trials
• Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials
• Adaptive two-stage optimal designs for phase II clinical studies that allow early futility stopping

This page was built for publication: Stopping for efficacy in single-arm phase II clinical trials